AU780439B2 - The use of mirtazapine for the treatment of sleep disorders - Google Patents

The use of mirtazapine for the treatment of sleep disorders Download PDF

Info

Publication number
AU780439B2
AU780439B2 AU30247/01A AU3024701A AU780439B2 AU 780439 B2 AU780439 B2 AU 780439B2 AU 30247/01 A AU30247/01 A AU 30247/01A AU 3024701 A AU3024701 A AU 3024701A AU 780439 B2 AU780439 B2 AU 780439B2
Authority
AU
Australia
Prior art keywords
mirtazapine
treatment
sleep
dose
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU30247/01A
Other languages
English (en)
Other versions
AU3024701A (en
Inventor
Gerardus Stephanus Franciscus Ruigt
Frans Van Den Berg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme BV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU3024701A publication Critical patent/AU3024701A/en
Application granted granted Critical
Publication of AU780439B2 publication Critical patent/AU780439B2/en
Assigned to N.V. ORGANON reassignment N.V. ORGANON Alteration of Name(s) in Register under S187 Assignors: AKZO NOBEL N.V.
Assigned to MSD OSS B.V. reassignment MSD OSS B.V. Request to Amend Deed and Register Assignors: N.V. ORGANON
Assigned to MERCK SHARP & DOHME B.V. reassignment MERCK SHARP & DOHME B.V. Request to Amend Deed and Register Assignors: MSD OSS B.V.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU30247/01A 2000-02-11 2001-02-06 The use of mirtazapine for the treatment of sleep disorders Expired AU780439B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00200499 2000-02-11
EP00200499 2000-02-11
PCT/EP2001/001221 WO2001058453A1 (en) 2000-02-11 2001-02-06 The use of mirtazapine for the treatment of sleep disorders

Publications (2)

Publication Number Publication Date
AU3024701A AU3024701A (en) 2001-08-20
AU780439B2 true AU780439B2 (en) 2005-03-24

Family

ID=8171013

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30247/01A Expired AU780439B2 (en) 2000-02-11 2001-02-06 The use of mirtazapine for the treatment of sleep disorders

Country Status (25)

Country Link
US (1) US6933293B2 (enExample)
EP (4) EP1257278B1 (enExample)
JP (1) JP5039994B2 (enExample)
KR (1) KR20020069371A (enExample)
CN (2) CN1395487A (enExample)
AR (1) AR027394A1 (enExample)
AT (1) ATE317261T1 (enExample)
AU (1) AU780439B2 (enExample)
BR (1) BR0108261A (enExample)
CA (1) CA2396209C (enExample)
CO (1) CO5271706A1 (enExample)
CZ (1) CZ302368B6 (enExample)
DE (1) DE60117122T2 (enExample)
DK (1) DK1257278T3 (enExample)
ES (1) ES2258071T3 (enExample)
HK (1) HK1049122B (enExample)
HU (1) HUP0204391A3 (enExample)
IL (2) IL150290A0 (enExample)
NO (1) NO328007B1 (enExample)
PE (1) PE20011080A1 (enExample)
PL (1) PL206073B1 (enExample)
RU (1) RU2270680C2 (enExample)
SK (1) SK287396B6 (enExample)
WO (1) WO2001058453A1 (enExample)
ZA (1) ZA200205238B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152055A1 (en) * 2003-01-30 2004-08-05 Gliessner Michael J.G. Video based language learning system
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
US20070298107A1 (en) * 2003-11-25 2007-12-27 Aurobindo Pharma Ltd. Pharmaceutical Compositions of Mirtazapine
GB0417558D0 (en) * 2004-08-06 2004-09-08 Merck Sharp & Dohme Novel combination therapy
KR100870381B1 (ko) * 2004-10-14 2008-11-25 다이킨 고교 가부시키가이샤 분위기개변방법, 그리고 이에 이용되는 분무제 및 분무장치
JP2006137748A (ja) * 2004-10-14 2006-06-01 Daikin Ind Ltd 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
JP2007284363A (ja) * 2006-04-13 2007-11-01 Daikin Ind Ltd 噴霧剤
CA2684021A1 (en) 2007-04-11 2008-10-23 N.V. Organon A method for the preparation of an enantiomer of a tetracyclic benzazepine
EP3261645B1 (en) 2015-02-27 2021-04-28 Dechra Limited Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999025356A1 (en) * 1997-11-14 1999-05-27 Akzo Nobel N.V. Use of mirtazapine for treating sleep apneas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
RU2107058C1 (ru) * 1992-10-07 1998-03-20 Акцо Нобель Н.В. Способ выделения энантиомеров из рацемической смеси
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999025356A1 (en) * 1997-11-14 1999-05-27 Akzo Nobel N.V. Use of mirtazapine for treating sleep apneas

Also Published As

Publication number Publication date
AR027394A1 (es) 2003-03-26
CZ302368B6 (cs) 2011-04-13
EP2283840A1 (en) 2011-02-16
US6933293B2 (en) 2005-08-23
CA2396209A1 (en) 2001-08-16
PL206073B1 (pl) 2010-06-30
WO2001058453A1 (en) 2001-08-16
CO5271706A1 (es) 2003-04-30
IL150290A (en) 2010-12-30
CZ20022330A3 (cs) 2002-11-13
IL150290A0 (en) 2002-12-01
HK1049122A1 (en) 2003-05-02
CN101229170A (zh) 2008-07-30
US20030022888A1 (en) 2003-01-30
RU2002124141A (ru) 2004-03-10
DE60117122D1 (de) 2006-04-20
HUP0204391A3 (en) 2005-03-29
HK1049122B (en) 2006-04-21
EP1656937A1 (en) 2006-05-17
RU2270680C2 (ru) 2006-02-27
NO20023803D0 (no) 2002-08-09
PE20011080A1 (es) 2001-10-18
CA2396209C (en) 2009-09-01
ES2258071T3 (es) 2006-08-16
BR0108261A (pt) 2003-03-05
JP5039994B2 (ja) 2012-10-03
DE60117122T2 (de) 2006-07-27
KR20020069371A (ko) 2002-08-30
DK1257278T3 (da) 2006-06-12
SK11442002A3 (sk) 2003-02-04
PL356721A1 (en) 2004-06-28
EP1658850A1 (en) 2006-05-24
SK287396B6 (sk) 2010-08-09
HUP0204391A2 (en) 2003-05-28
NO328007B1 (no) 2009-11-09
JP2003522147A (ja) 2003-07-22
EP1257278B1 (en) 2006-02-08
AU3024701A (en) 2001-08-20
EP1257278A1 (en) 2002-11-20
ZA200205238B (en) 2003-09-29
NO20023803L (no) 2002-10-09
CN1395487A (zh) 2003-02-05
ATE317261T1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
AU780439B2 (en) The use of mirtazapine for the treatment of sleep disorders
NZ196048A (en) Anti-depressant compositions with reduced induction of drowsiness-benzodiazepine tranquilliser/m-(chloro or fluoro)-t-butylaminopropiophenone
WO2008085567A1 (en) Methods of using low-dose doxepin for the improvement of sleep
Schück et al. Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers
RU2268725C2 (ru) Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств
JPH0920666A (ja) 成熟遅延および類似疾患の治療用医薬組成物
Mendelson Pharmacotherapy of insomnia
HK1150978A (en) The use of mirtazapine for the treatment of sleep disorders
HK1087356A (en) The use of mirtazapine for the treatment of sleep disorders
HK1087359A (en) The use of mirtazapine for the treatment of sleep disorders
Kerr et al. The effects of acute and repeated doses of moclobemide on psychomotor performance and cognitive function in healthy elderly volunteers
MXPA02006710A (en) The use of mirtazapine for the treatment of sleep disorders
TWI297607B (en) The use of mirtazapine for the treatment of sleep disorders and pharmaceutical composition comprising mirtazapine
Fairweather et al. The psychomotor and cognitive effects of litoxetine in young and middle aged volunteers.
Laddha et al. Drugs impairment on driving performance: an overview
Pollack et al. Variables in the clinical evaluation of a hypnotic drug with a clinical evaluation of glutethimide
MEADOR-WOODRUFF et al. SINGLE CASE STUDY: Profound Behavioral Toxicity due to Tricyclic Antidepressants
EP4376954A1 (en) Lemborexant for use in methods of treating irregular sleep-wake rhythm disorder and circadian rhythm sleep disorders associated with neurodegenerative diseases
Fink et al. Electroencephalographic measures for pharmacodynamic analysis of psychoactive drugs in man
Armstrong Prevention of traveller's diarrhea with doxycycline
Kimball Altered states of consciousness: Functional and organic brain syndromes

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired